Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common
complications affecting solid organ transplant recipients, conveying higher risks of …

Cytomegalovirus (CMV) is a leading opportunistic infection in immune compromised
patients, including allogeneic hematopoietic stem cell (HSCT) or solid organ transplant …

Cytomegalovirus (CMV) is one of the most common opportunistic infections that affect the
outcome of solid organ transplantation. This updated guideline from the American Society of …

Background Ganciclovir-resistant (ganR) cytomegalovirus (CMV) is an emerging and
important problem in solid organ transplant (SOT) recipients. Only through direct comparison …

Mutations in CMV genes can be selected during antiviral drug exposure, and manifests
phenotypically as nonresponsive drug-resistant disease. Knowledge of specific mutations …

Cytomegalovirus (CMV) infection can have both direct and indirect effects after solid-organ
transplantation, with a significant impact on transplant outcomes. Prevention strategies …

Cytomegalovirus (CMV) is a significant human pathogen, especially for
immunocompromised patients, often treated with one or more antiviral drugs. Although the …

Herpesviruses can either cause primary infection or may get reactivated after both
hematopoietic cell and solid organ transplantations. In general, viral infections increase post …

With advancements in immunosuppressive drugs, induction regimens, standardization of
surgical techniques and improved postoperative care, survival is increasing. In due course, it …

Human cytomegalovirus (CMV) is a double-stranded DNA virus and member of the herpes
virus family. Infection prevalence reaches 60% to 80% by adulthood in the United States and …